Sort
24,827 grants matching “epilepsy”
Integrative genomics to map risk genes and pathways in autism and epilepsy
$760,914Dalila Pinto · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · MH
Circadian changes in network excitability and Alzheimer disease pathogenesis
$760,861Erik D Roberson · University Of Alabama At Birmingham · R01 · FY2021 · AG
Type 1 Diabetes and Depression: Role of Brain Glutamate
$760,823Nicolas R. Bolo · Beth Israel Deaconess Medical Center · R01 · FY2010 · DK
Brain Imaging And Modeling
$760,614Barry Horwitz · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC
Glutamate receptors and human neurological disease
$760,572Stephen F. Traynelis · Emory University · R35 · FY2021 · NS
Invasive decoding and stimulation of altered reward computations in depression
$760,473Ignacio Saez · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH
Childhood Absence Epilepsy: Coordinating Center
$760,344Avital Cnaan · Children'S Hosp Of Philadelphia · U01 · FY2008 · NS
Scalable tool and comprehensive maps to interpret structural variation across the neuropsychiatric spectrum
$760,312Michael E Talkowski · Broad Institute, Inc. · R01 · FY2024 · MH
WATCHING ACTION POTENTIALS IN INTACT NEURONAL CIRCUITS
$760,000Timothy E Holy · Washington University · DP1 · FY2010 · OD
WATCHING ACTION POTENTIALS IN INTACT NEURONAL CIRCUITS
$760,000Timothy E Holy · Washington University · DP1 · FY2009 · OD
Discovering Biology for Neuropsychiatric Diseases Through Omics Studies on Comorbidities
$759,644Ela W Knapik · Vanderbilt University Medical Center · R01 · FY2017 · MH
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
$758,641Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2023 · NS
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
$758,516Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2025 · NS
The glial mechanism for electrical brain stimulation
$758,317Gregory A Worrell · Mayo Clinic Rochester · R01 · FY2019 · NS
Neurodevelopmental defects of the thalamocortical pathway as a convergent feature of psychiatric disorders
$758,205Tomasz Nowakowski · University Of California, San Francisco · R01 · FY2023 · MH
Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathology
$758,149Thota Ganesh · Emory University · U01 · FY2016 · AG
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain
$758,000John C Newman · Buck Institute For Research On Aging · R01 · FY2022 · AG
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain
$758,000John C Newman · Buck Institute For Research On Aging · R01 · FY2024 · AG
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain
$758,000John C Newman · Buck Institute For Research On Aging · R01 · FY2023 · AG
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain
$758,000John C Newman · Buck Institute For Research On Aging · R01 · FY2021 · AG
Apoptosis In Neurodegenerative Disorders
$757,027Mark Mattson · National Institute On Aging · ZIA · FY2016 · AG
EPILEPSY AND THE WNT SIGNALING PATHWAY
$756,982The Regents Of The University Of Colorado · · FY2010 · Department of Defense
Neurodevelopmental defects of the thalamocortical pathway as a convergent feature of psychiatric disorders
$756,868Tomasz Nowakowski · University Of California, San Francisco · R01 · FY2024 · MH
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
$756,847Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2024 · NS
Next generation in-vivo diffusion imaging at submillimeter resolution
$756,795Kawin Setsompop · Stanford University · R01 · FY2025 · MH